J&J Q2 2021 profit soars – ‘our strategy is working’, says exec
Personal care major Johnson & Johnson (J&J) has reported a significant surge in net earnings for the second quarter (Q2) of 2021, largely propelled by its medical device and pharma divisions, but consumer health also returned to growth.